MIC1 Antibodies

Santa Cruz Biotechnology features a diverse variety of MIC1 monoclonal antibodies for research focused on understanding MIC1 protein function. MIC1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MIC1, also known as growth differentiation factor 15 (GDF15), is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a crucial role in regulating inflammation, apoptosis, and cellular stress responses. MIC1 expression increases significantly in various pathological conditions, including cancer and cardiovascular diseases, making it an important biomarker for disease progression and therapeutic response. Research has shown that MIC1 signaling pathways influence cell survival, differentiation, and metabolic regulation. Understanding MIC1 function continues to reveal new possibilities for therapeutic interventions and disease monitoring. Recent studies have highlighted MIC1's potential as a therapeutic target in multiple disease states. Investigating MIC1 mechanisms can lead to breakthroughs in understanding disease development and progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of MIC1's role in health and disease.